Business, but not as usual
What the Neighbours Say
Human platelet IgG Fc receptor FcγRIIA in immunity and thrombosis
Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management
Does the response to aspirin and clopidogrel vary over 6 months in patients with ischemic heart disease?
High on-treatment platelet reactivity with ticagrelor versus prasugrel: a systematic review and meta-analysis
Of men and meals
Antithrombotic therapy for left ventricular assist devices in adults: a systematic review
CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease
Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A
Early hemostatic responses to trauma identified with hierarchical clustering analysis
Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy
Tumor oncogene ( KRAS ) status and risk of venous thrombosis in patients with metastatic colorectal cancer
Qualitative point-of-care D-dimer testing compared with quantitative D-dimer testing in excluding pulmonary embolism in primary care
Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis
Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study
Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study
Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations
Index clinical manifestation of venous thromboembolism predicts early recurrence type and frequency: a meta-analysis of randomized controlled trials
Selective disruption of heparin and antithrombin-mediated regulation of human factor IX
Unconjugated bilirubin inhibits proteolytic cleavage of von Willebrand factor by ADAMTS13 protease
Survival advantage of heterozygous factor V Leiden carriers in murine sepsis
New clues regarding the mysterious mechanism of activated thrombin-activatable fibrinolysis inhibitor self-destruction
Generation of a stable thrombin-activatable fibrinolysis inhibitor deletion mutant exerting full carboxypeptidase activity without activation
Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model
The gene expression signature of anagrelide provides an insight into its mechanism of action and uncovers new regulators of megakaryopoiesis
Increased expression of HIF2α during iron deficiency–associated megakaryocytic differentiation
Platelet and endothelial cell P-selectin are required for host defense against Klebsiella pneumoniae -induced pneumosepsis
Akt and mitogen-activated protein kinase enhance C-type lectin-like receptor 2-mediated platelet activation by inhibition of glycogen synthase kinase 3α/β
Establishment of the WHO 1st International Standard ADAMTS13, plasma (12/252): communication from the SSC of the ISTH
Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH
Hospital-acquired anemia: the contribution of diagnostic blood loss
Iatrogenic anemia/Twenty-five million liters of blood into the sewer: comment
Iatrogenic anemia/Twenty-five million liters of blood into the sewer: reply
Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis: comment
Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis: reply
Real-world variability in dabigatran levels in patients with atrial fibrillation: comment
Real-world variability in dabigatran levels in patients with atrial fibrillation: reply